phase readout

NCT05805501: A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

ACTIVE_NOT_RECRUITINGupdated 4d ago

community read0 votes

Sponsor: Hoffmann-La Roche. Phase: PHASE2. Conditions: Renal Cell Carcinoma

Data sources

last refreshed 2h ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?